237
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

The Role of Multiple Imputation in Noninferiority Trials for Binary Outcomes

&
Pages 57-69 | Received 05 Mar 2017, Published online: 26 Mar 2018

References

  • Cochran, W. G. (1954), “Some Methods for Strengthening the Common χ2 Tests,” Biometrics, 10, 417–451.
  • Collins, L. M., Schafer, J. L., and Kam, C. M. (2001), “A Comparison of Inclusive and Restrictive Strategies in Modern Missing Data Procedures,” Psychological Methods, 6, 330–351.
  • Farrington, C. P., and Manning, G. (1990), “Test Statistics and Sample Size Formulae for Comparative Binomial Trials With Null Hypothesis of Non-Zero Risk Difference or Non-Unity Relative Risk,” Statistics in Medicine, 9, 1447–1454.
  • Food and Drug Administration (2016), Non-Inferiority Clinical Trials to Establish Effectiveness: Guidance for Industry, Silver Spring, MD: U.S. Department of Health and Human Services, available at https://www.fda.gov/downloads/Drugs/…/Guidances/UCM202140.pdf.
  • Gallo, P., and Chuang-Stein, C. (2009), “A Note on Missing Data in Noninferiority Trials,” Drug Information Journal, 43, 469–474.
  • Lipkovich, I., Duan, Y., and Ahmed, S. (2005), “Multiple Imputation Compared with REPL and GEE for Analysis of Binary Repeated Measures in Clinical Studies,” Pharmaceutical Statistics, 4, 267–285.
  • Little, R. J. A., and Rubin, D. B. (2002), Statistical Analysis with Missing Data (2nd ed.), New York: Wiley.
  • Li, E., Wang, N., and Wang, N.-Y. (2007), “Joint Models for a Primary Endpoint and Multiple Longitudinal Covariate Processes,” Biometrics, 63, 1068–1078.
  • Liu, G. F., and Pang, L. (2017), “Control-Based Imputation and Delta-Adjustment Stress Test for Missing Data Analysis in Longitudinal Clinical Trials,” Statistics in Biopharmaceutical Research, 9, 186–194.
  • Liublinska, V., and Rubin, D. B. (2014), “Sensitivity Analysis for a Partially Missing Binary Outcome in a Two-Arm Randomized Clinical Trial,” Statistics in Medicine, 33, 4170–4185.
  • Mallinckrodt, C., and Lipkovich, I. (2016), Analyzing Longitudinal Clinical Trial Data: A Practical Guide, Boca Raton, FL: Chapman and Hall.
  • Mantel, N., and Haenszel, W. (1959), “Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease,” Journal of the National Cancer Institute, 22, 719–748.
  • Nassiri, V., Molenberghs, G., and Verbeke. G. (2017), “A Simple, Principled Rule to Determine the Number of Multiple Imputations,” Submitted for Publication.
  • National Research Council (2010), “The Prevention and Treatment of Missing Data in Clinical Trials,” Panel on Handling Missing Data in Clinical Trials, Committee on National Statistics, Division of Behavioural and Social Sciences and Education, Washington, DC: The National Academies Press.
  • Ratitch, B., O'Kelly, M., and Tosiello, R. (2013), “Missing Data in Clinical Trials: From Clinical Assumptions to Statistical Analysis Using Pattern Mixture Models,” Pharmaceutical Statistics, 12, 337–347.
  • Rothmann, M. D., Wiens, B. L., and Chan, I. S. F. (2012), Design and Analysis of Non-Inferiority Trials, Boca Raton, FL: Chapman & Hall.
  • Reeve, R. (2016), “Confidence Interval of Difference of Proportions in Logistic Regression in Presence of Covariates,” Statistical Methods in Medical Research, pii, 0962280216631583. [Epub ahead of print].
  • Rubin, D. B. (1987), Multiple Imputation for Nonresponse in Surveys, New York: Wiley.
  • SAS Institute Inc. (2013), SAS/STAT® 9.4 User's Guide, Cary, NC: Author.
  • Schomaker, M., and Heumann, C. (2016), “Bootstrap Inference When Using Multiple Imputation,” arXiv:1602.07933 available at https://arxiv.org/abs/1602.07933.
  • Tang, Y. (2017), “An Efficient Multiple Imputation Algorithm for Control-Based and Delta-Adjusted Pattern Mixture Models using SAS,” Statistics in Biopharmaceutical Research, 9, 116–125.
  • van Buuren, S. (2012), Flexible Imputation of Missing Data, Boca Raton, FL: CRC Press.
  • van Buuren, S., and Groothuis-Oudshoorn, K. (2011), “mice: Multivariate Imputation by Chained Equations in R,” Journal of Statistical Software, 45, 1–67.
  • Wiens, B. L. (2015), “Controversial (Unresolved) Issues in Noninferiority Trials,” in Clinical Trial Biostatistics and Biopharmaceutical Applications, eds. W. R. Young and D.-G. Chen, Boca Raton, FL: CRC Press.
  • Wiens, B. L., and Rosenkranz, G. (2013), “Missing Data in Non-inferiority trials,” Statistics in Biopharmaceutical Research, 5, 383–393.
  • Wiens, B. L., and Zhao, W. (2007), “The Role of Intention to Treat in Analysis of Noninferiority Studies,” Clinical Trials: Journal of the Society for Clinical Trials, 4, 286–291.
  • Yan, X., Lee, S., and Li, N. (2009), “Missing Data Handling Methods in Medical Device Clinical Trials,” Journal of Biopharmaceutical Statistics, 19, 1085–1098.
  • Yanagawa, T., Tango, T., and Hiejima, Y. (1994), “Mantel-Haenszel-Type Tests for Testing Equivalence or More Than Equivalence in Comparative Clinical Trials,” Biometrics, 50, 859–864.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.